Analysts weighed in with favorable reports on pharmaceutical companies Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP).
Synergy Pharmaceuticals Inc (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced that Gary L. Sender has resigned as the company’s Chief Financial Officer for personal reasons, effective April 30, …
Seadrill Ltd (NYSE:SDRL) is up nearly 4% in pre-market up to $4.35 after oil rebounded yesterday.
Shares of drug maker Synergy Pharmaceuticals Inc (NASDAQ:SGYP) rose nearly 9% today after the FDA has accepted the company’s plecanatide for review, allowing investors to breathe a …
International Business Machines Corp. (NYSE:IBM) is down over 5% in pre-market trading after the company posted its Q1:16 revenues yesterday after market close.
Healthcare analysts from Mizuho and Rodman and Renshow explain their views on recent announcements made by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Synergy …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the appointment of Marino Garcia to the newly created role of Executive Vice President and Chief Strategy Officer, effective …
While Canadian drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced the return of Mike Pearson as CEO, biopharma firm Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported its …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results …
